Genetic testing could lead to life insurance discrimination

26 October 2017
| By Jassmyn |
image
image
expand image

The insurance industry needs to prepare an effective response to the threat that genetic testing and those results in life insurance could be used in underwriting and lead to discrimination, the Actuaries Institute believes.

The institute’s report, ‘Genetics – A Testing Time for Insurers’, said that even a small rise in the number of genetic tests could lead to significant increases in life insurance claims costs.

The authors, Alan Doble and Jessica Chen, said the impact of declining tests costs and greater public interest in ancestry and health was driving increased genetic testing.

“For the life insurance industry, if health information known to the insurance applicant is not disclosed, it may be expected to lead to anti-selection, increasing premiums and ultimately impacting the financial sustainability of the industry,” the report said.

“Conversely, if it is known that genetic test information may need to be disclosed for use in underwriting life insurance policies, that may deter people from undertaking a test that could benefit their wellbeing.

“This creates a fundamental tension between the desire for insurance providers to be inclusive and not discriminate between insurance applicants, and the sustainability of insurance companies’ business models in the presence of information asymmetry and potential anti-selection.”

‘Anti-selection’ would occur when those who found they had an increased risk of future disease could still obtain life insurance at standard rates. Insurers would then fear premium rates would need to increase to cover the extra insurance claims costs.

The report said these extra costs could lead to those who were healthy to drop out of life insurance, and that insurers would find themselves with a pool of insured lives that were becoming potentially less healthy, and would force premiums higher.

"…there are complex issues for life insurance regarding genetic testing, cover availability and affordability. What needs to be resolved is a good response to the threat that test results may be used in life insurance underwriting and lead to discrimination.” Chen said.

The report noted that as most Australians could obtain life insurance cover without disclosing medical information, genetic testing would more likely have an impact on voluntary retail cover or increased cover sought under group insurance.

Read more about:

AUTHOR

Add new comment

The content of this field is kept private and will not be shown publicly.

Recommended for you

sidebar subscription

Never miss the latest developments in Super Review! Anytime, Anywhere!

Grant Banner

From my perspective, 40- 50% of people are likely going to be deeply unhappy about how long they actually live. ...

4 months ago
Kevin Gorman

Super director remuneration ...

4 months 1 week ago
Anthony Asher

No doubt true, but most of it is still because over 45’s have been upgrading their houses with 30 year mortgages. Money ...

4 months 1 week ago

Australia’s second-largest super fund has confirmed it is expanding its presence in the UK following significant investment in the region....

14 hours ago

While the Financial Advice Association Australia said it supports a performance testing regime “in principle”, it holds reservations about expanding this scope to retirem...

4 hours 49 minutes ago

The property group, owned by industry super fund Aware Super, has announced two new projects with a total construction value of $320 million that will add more than 700 h...

21 hours 56 minutes ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND